BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
298 results:

  • 1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
    Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
    Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
    [No Abstract]    [Full Text] [Related]  

  • 4. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
    Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
    Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 7. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multidimensional Analysis of PANoptosis-Related Molecule CASP8: Prognostic Significance, Immune Microenvironment Effect, and Therapeutic Implications in Hepatocellular Carcinoma.
    Peng F; Zhu F; Cao B; Peng L
    Genet Res (Camb); 2023; 2023():2406193. PubMed ID: 38186679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma.
    Zhang J; Hao W; Liu X; Meng Y; Liu J; Wu L; Zhang Y; Hu X; Fan Y; Qin X
    Clin Chim Acta; 2024 Feb; 554():117727. PubMed ID: 38123112
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
    Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
    Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
    Vylegzhanina AV; Bespalov IA; Novototskaya-Vlasova KA; Hall BM; Gleiberman AS; Yu H; Leontieva OV; Leonova KI; Kurnasov OV; Osterman AL; Dy GK; Komissarov AA; Vasilieva E; Gehlhausen J; Iwasaki A; Ambrosone CB; Tsuji T; Matsuzaki J; Odunsi K; Andrianova EL; Gudkov AV
    Cancer Res Commun; 2023 Nov; 3(11):2256-2267. PubMed ID: 37870410
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TEDC2 plays an oncogenic role and serves as a therapeutic target of hepatocellular carcinoma.
    Li Y; Guo B; Wang L; Zhou F; Yu Z; Huang Y; Chen R; Zhang M; Zhang K; Zheng L; Jing S; Hong W; Han T
    Dig Liver Dis; 2024 May; 56(5):861-871. PubMed ID: 37867019
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of TOP2A and CDC6 in liver cancer.
    Jia W; Liu X; Zhang Z
    Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
    Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
    JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].
    Wu YJ; Liu S; Tian YQ; Fan ZJ; Zhang L; Liu SY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):869-876. PubMed ID: 37723070
    [No Abstract]    [Full Text] [Related]  

  • 18. SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma.
    Nong J; Yang K; Li T; Lan C; Zhou X; Liu J; Xie H; Luo J; Liao X; Zhu G; Peng T
    Aging (Albany NY); 2023 Aug; 15(16):8408-8432. PubMed ID: 37632835
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Analysis of clinicopathological features of 18 cases of hepatic angiosarcoma].
    Zhou YY; Wang H; Xian ZH; Cong WM; Dong H
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):729-735. PubMed ID: 37580256
    [No Abstract]    [Full Text] [Related]  

  • 20. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
    Fan Z; Jin M; Zhang L; Wang N; Li M; Wang C; Wei F; Zhang P; Du X; Sun X; Qiu W; Wang M; Wang H; Shi X; Ye J; Jiang C; Zhou J; Chai W; Qi J; Li T; Zhang R; Liu X; Huang B; Chai K; Cao Y; Mu W; Huang Y; Yang T; Zhang H; Qu L; Liu Y; Wang G; Lv G
    Gut; 2023 Nov; 72(11):2149-2163. PubMed ID: 37549980
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.